Skip to main content

Table 3 Prevalence of baseline anemia related to different characteristics of cervical cancer patients in TASH cancer center, Ethiopia (n = 634)

From: Prevalence and associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia

Variables

Code

Baseline anemia

Yes

No

Frequency

(%)

Frequency

(%)

Age

< 30

30

50.85

29

49.15

30–39

44

36.97

75

63.02

40–49

95

57.92

69

42.07

50–59

87

56.13

68

43.87

≥ 60

67

48.91

70

51.09

Residence

Urban

184

51.83

171

48.17

Rural

139

49.82

140

50.18

Region

Amhara

83

51.55

78

48.45

Oromia

103

50.74

100

49.26

Tigray

18

78.26)

5

21.74

SNNP

32

53.33

28

46.67

Addis Ababa

77

46.11

90

53.89

Others

10

50.00

10

50.00

Occupation

Gov’t employee

42

49.41

43

50.59

Merchant

40

54.79

33

45.20

Farmer

60

51.28

57

48.71

House wife

133

49.44

136

50.56

Others

48

53.33

42

46.67

Substance use

User

73

68.86

33

31.13

None user

250

47.35

278

52.65

Children

No child

8

40.00

12

60.00

One

20

48.78

21

51.22

Two

42

45.65

50

54.35

Three

115

53.49

100

46.51

More than 3

138

51.88

128

48.12

Marital status

Married

218

53.56

189

46.44

Single

13

41.94

18

58.06

Widowed

48

48.98

50

51.02

Divorced

44

44.89

54

55.10

Stage

Stage I

26

41.26

37

58.73

Stage II

70

44.31

88

55.69

Stage III

118

46.27

137

53.72

Stage IV

109

68.99

49

31.01

Histopathology

Squamous cell

299

52.09

275

47.91

Adenocarcinoma

24

40.00

36

60.00

Comorbidity

Yes

152

71.70)

60

28.30

No

171

40.52

251

59.48

Comorbidity types (n = 212)

HIV

90

76.27

28

23.73

Hypertension

31

63.27

18

36.73

Others

21

44.68

16

34.04